biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > What do YOU want?

<< Previous

Bullboard Posts

Next >>

Comment by darniton Mar 17, 2022 8:32pm

87 Views

Post# 34523803

RE:What do YOU want?

JD, Over the last 30 years on the net I've watched a few people fail about, lashing out at those they imagine are responsible for their losses and misery. You will be remembered not for your helping investors, but for your own self destructive hubris and demise. No matter how much you bluster and threaten, the die is cast, and no matter what you do, BTI's results will be totally independent of your efforts. I'll stop back and see how you are coping in the future.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity